Copyright Reports & Markets. All rights reserved.

Global Rubella ELISA Kits Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Rubella ELISA Kits Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 IgM
    • 1.3.3 IgG
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Rubella ELISA Kits Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Laboratory
    • 1.4.3 Colleges
    • 1.4.4 Others
  • 1.5 Global Rubella ELISA Kits Market Size & Forecast
    • 1.5.1 Global Rubella ELISA Kits Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Rubella ELISA Kits Sales Quantity (2021-2032)
    • 1.5.3 Global Rubella ELISA Kits Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 MyBioSource
    • 2.1.1 MyBioSource Details
    • 2.1.2 MyBioSource Major Business
    • 2.1.3 MyBioSource Rubella ELISA Kits Product and Services
    • 2.1.4 MyBioSource Rubella ELISA Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 MyBioSource Recent Developments/Updates
  • 2.2 BosterBio
    • 2.2.1 BosterBio Details
    • 2.2.2 BosterBio Major Business
    • 2.2.3 BosterBio Rubella ELISA Kits Product and Services
    • 2.2.4 BosterBio Rubella ELISA Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 BosterBio Recent Developments/Updates
  • 2.3 Novus Biologicals
    • 2.3.1 Novus Biologicals Details
    • 2.3.2 Novus Biologicals Major Business
    • 2.3.3 Novus Biologicals Rubella ELISA Kits Product and Services
    • 2.3.4 Novus Biologicals Rubella ELISA Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Novus Biologicals Recent Developments/Updates
  • 2.4 Abbexa
    • 2.4.1 Abbexa Details
    • 2.4.2 Abbexa Major Business
    • 2.4.3 Abbexa Rubella ELISA Kits Product and Services
    • 2.4.4 Abbexa Rubella ELISA Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Abbexa Recent Developments/Updates
  • 2.5 IBL- America
    • 2.5.1 IBL- America Details
    • 2.5.2 IBL- America Major Business
    • 2.5.3 IBL- America Rubella ELISA Kits Product and Services
    • 2.5.4 IBL- America Rubella ELISA Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 IBL- America Recent Developments/Updates
  • 2.6 DEMEDITEC Diagnostics
    • 2.6.1 DEMEDITEC Diagnostics Details
    • 2.6.2 DEMEDITEC Diagnostics Major Business
    • 2.6.3 DEMEDITEC Diagnostics Rubella ELISA Kits Product and Services
    • 2.6.4 DEMEDITEC Diagnostics Rubella ELISA Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 DEMEDITEC Diagnostics Recent Developments/Updates
  • 2.7 Abnova Corporation
    • 2.7.1 Abnova Corporation Details
    • 2.7.2 Abnova Corporation Major Business
    • 2.7.3 Abnova Corporation Rubella ELISA Kits Product and Services
    • 2.7.4 Abnova Corporation Rubella ELISA Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Abnova Corporation Recent Developments/Updates
  • 2.8 Biorbyt
    • 2.8.1 Biorbyt Details
    • 2.8.2 Biorbyt Major Business
    • 2.8.3 Biorbyt Rubella ELISA Kits Product and Services
    • 2.8.4 Biorbyt Rubella ELISA Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Biorbyt Recent Developments/Updates
  • 2.9 United States Biological
    • 2.9.1 United States Biological Details
    • 2.9.2 United States Biological Major Business
    • 2.9.3 United States Biological Rubella ELISA Kits Product and Services
    • 2.9.4 United States Biological Rubella ELISA Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 United States Biological Recent Developments/Updates
  • 2.10 XpressBio
    • 2.10.1 XpressBio Details
    • 2.10.2 XpressBio Major Business
    • 2.10.3 XpressBio Rubella ELISA Kits Product and Services
    • 2.10.4 XpressBio Rubella ELISA Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 XpressBio Recent Developments/Updates
  • 2.11 Wuhan Fine Biotech
    • 2.11.1 Wuhan Fine Biotech Details
    • 2.11.2 Wuhan Fine Biotech Major Business
    • 2.11.3 Wuhan Fine Biotech Rubella ELISA Kits Product and Services
    • 2.11.4 Wuhan Fine Biotech Rubella ELISA Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Wuhan Fine Biotech Recent Developments/Updates

3 Competitive Environment: Rubella ELISA Kits by Manufacturer

  • 3.1 Global Rubella ELISA Kits Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Rubella ELISA Kits Revenue by Manufacturer (2021-2026)
  • 3.3 Global Rubella ELISA Kits Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Rubella ELISA Kits by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Rubella ELISA Kits Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Rubella ELISA Kits Manufacturer Market Share in 2025
  • 3.5 Rubella ELISA Kits Market: Overall Company Footprint Analysis
    • 3.5.1 Rubella ELISA Kits Market: Region Footprint
    • 3.5.2 Rubella ELISA Kits Market: Company Product Type Footprint
    • 3.5.3 Rubella ELISA Kits Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Rubella ELISA Kits Market Size by Region
    • 4.1.1 Global Rubella ELISA Kits Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Rubella ELISA Kits Consumption Value by Region (2021-2032)
    • 4.1.3 Global Rubella ELISA Kits Average Price by Region (2021-2032)
  • 4.2 North America Rubella ELISA Kits Consumption Value (2021-2032)
  • 4.3 Europe Rubella ELISA Kits Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Rubella ELISA Kits Consumption Value (2021-2032)
  • 4.5 South America Rubella ELISA Kits Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Rubella ELISA Kits Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Rubella ELISA Kits Sales Quantity by Type (2021-2032)
  • 5.2 Global Rubella ELISA Kits Consumption Value by Type (2021-2032)
  • 5.3 Global Rubella ELISA Kits Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Rubella ELISA Kits Sales Quantity by Application (2021-2032)
  • 6.2 Global Rubella ELISA Kits Consumption Value by Application (2021-2032)
  • 6.3 Global Rubella ELISA Kits Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Rubella ELISA Kits Sales Quantity by Type (2021-2032)
  • 7.2 North America Rubella ELISA Kits Sales Quantity by Application (2021-2032)
  • 7.3 North America Rubella ELISA Kits Market Size by Country
    • 7.3.1 North America Rubella ELISA Kits Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Rubella ELISA Kits Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Rubella ELISA Kits Sales Quantity by Type (2021-2032)
  • 8.2 Europe Rubella ELISA Kits Sales Quantity by Application (2021-2032)
  • 8.3 Europe Rubella ELISA Kits Market Size by Country
    • 8.3.1 Europe Rubella ELISA Kits Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Rubella ELISA Kits Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Rubella ELISA Kits Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Rubella ELISA Kits Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Rubella ELISA Kits Market Size by Region
    • 9.3.1 Asia-Pacific Rubella ELISA Kits Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Rubella ELISA Kits Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Rubella ELISA Kits Sales Quantity by Type (2021-2032)
  • 10.2 South America Rubella ELISA Kits Sales Quantity by Application (2021-2032)
  • 10.3 South America Rubella ELISA Kits Market Size by Country
    • 10.3.1 South America Rubella ELISA Kits Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Rubella ELISA Kits Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Rubella ELISA Kits Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Rubella ELISA Kits Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Rubella ELISA Kits Market Size by Country
    • 11.3.1 Middle East & Africa Rubella ELISA Kits Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Rubella ELISA Kits Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Rubella ELISA Kits Market Drivers
  • 12.2 Rubella ELISA Kits Market Restraints
  • 12.3 Rubella ELISA Kits Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Rubella ELISA Kits and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Rubella ELISA Kits
  • 13.3 Rubella ELISA Kits Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Rubella ELISA Kits Typical Distributors
  • 14.3 Rubella ELISA Kits Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Rubella ELISA Kits market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    Rubella ELISA Kits refer to Enzyme-Linked Immunosorbent Assay kits used for the detection and quantification of antibodies specific to the Rubella virus. Rubella, also known as German measles, is a highly contagious viral infection that can cause birth defects in pregnant women and serious complications in non-immune individuals. These ELISA kits utilize specific antigen-antibody interactions to detect the presence of Rubella-specific antibodies in patient samples, such as blood serum or plasma. The kits typically include pre-coated microplates, Rubella antigen, detection antibodies, and necessary reagents, allowing for sensitive and specific detection of Rubella antibodies and aiding in diagnostic procedures.
    The industry trend for Rubella ELISA Kits is on a positive trajectory due to various factors. Firstly, the emphasis on preventive healthcare and immunization programs worldwide has created a demand for diagnostic tools that can accurately detect Rubella infection and immunity. Additionally, the increase in international travel and migration has raised concerns about the spread of Rubella, necessitating screening and surveillance methods. Moreover, advancements in technology and the development of more sensitive and specific Rubella ELISA kits contribute to the growth of the market. Overall, the industry trend demonstrates a rising demand for Rubella ELISA kits, driven by the need for effective detection and control of Rubella infections.
    This report is a detailed and comprehensive analysis for global Rubella ELISA Kits market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Rubella ELISA Kits market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Rubella ELISA Kits market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Rubella ELISA Kits market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Rubella ELISA Kits market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Rubella ELISA Kits
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Rubella ELISA Kits market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include MyBioSource, BosterBio, Novus Biologicals, Abbexa, IBL- America, DEMEDITEC Diagnostics, Abnova Corporation, Biorbyt, United States Biological, XpressBio, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Rubella ELISA Kits market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    IgM
    IgG
    Market segment by Application
    Laboratory
    Colleges
    Others
    Major players covered
    MyBioSource
    BosterBio
    Novus Biologicals
    Abbexa
    IBL- America
    DEMEDITEC Diagnostics
    Abnova Corporation
    Biorbyt
    United States Biological
    XpressBio
    Wuhan Fine Biotech
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Rubella ELISA Kits product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Rubella ELISA Kits, with price, sales quantity, revenue, and global market share of Rubella ELISA Kits from 2021 to 2026.
    Chapter 3, the Rubella ELISA Kits competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Rubella ELISA Kits breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Rubella ELISA Kits market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Rubella ELISA Kits.
    Chapter 14 and 15, to describe Rubella ELISA Kits sales channel, distributors, customers, research findings and conclusion.

    Buy now